United Kingdom· GB-APID-17341211000001107
Depo-Medrone with Lidocaine suspension for injection 1ml vials
A medicinal product containing methylprednisolone + lidocaine, registered in United Kingdom by Mawdsley-Brooks & Company Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Methylprednisolone + Lidocaine
- Manufacturer
- Mawdsley-Brooks & Company Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Methylprednisolone + lidocaine in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandDepo Medrol Lidocain
- SwedenDepo-Medrol cum lidocain 40 mg/ml+10 mg/ml Injektionsvätska, suspensionOrifarm AB
- NetherlandsDepo Medrol + Lidocaïne, suspensie voor injectiePfizer B.V.
- PolandDepo-Medrol z LidokainąPfizer Europe MA EEIG
- IrelandDepo-Medrone 40mg/ml with Lidocaine 10mg/ml Suspension for Injection, 2ml vialPfizer Healthcare Ireland Unlimited Company
- FinlandDepo-Medrol Cum LidocainPfizer Oy
- CanadaDEPO-MEDROL WITH LIDOCAINEPFIZER CANADA ULC
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Belgium · Depo-Medrol + Lidocain, Depo-Medrol + Lidocaïne
- Finland · Depo-Medrol Cum Lidocain
- Ireland · Depo-Medrone With Lidocaine
- Italy · Lidodepomedrol
- Luxembourg · Depo-Medrol + Lidocain, Depo-Medrol + Lidocaïne
- Netherlands · Depo-Medrol + Lidocaïne
- Poland · Depo-Medrol Z Lidokainą
- Portugal · Depo-Medrol Com Lidocaína
- Sweden · Depo-Medrol Cum Lidocain
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c06bb88e-c3b0-4a1a-bc74-ee1f67b07dcd GET /v1/drugs/c06bb88e-c3b0-4a1a-bc74-ee1f67b07dcd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "17341211000001107",
"desc": "Depo-Medrone with Lidocaine suspension for injection 1ml vials (Mawdsley-Brooks & Company Ltd)",
"form": "Suspension for injection",
"vpid": "36034411000001107",
"source": "dmd",
"vtm_id": "776529001",
"strength": "10 mg",
"substance": "Methylprednisolone + Lidocaine",
"ingredient": "Lidocaine hydrochloride",
"supplier_code": "15125811000001100"
}See everything about methylprednisolone + lidocaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.